Search research articles
Contact Us
Filters
Showing results (21-30 of 31) with videos related to
Page
of 4
Sort By:
Clinical and Experimental Rheumatology
|
October 3, 2009
Pronounced interferon-alpha production from plasmacytoid dendritic cells in patients with Behçet's disease following CpG D ODN stimulation
S Pay, A Pekel, I Simsek, et al.
Rheumatology International
|
October 6, 2005
Serum interleukin-18 levels in patients with Behçet's disease. Is its expression associated with disease activity or clinical presentations?
U Musabak, S Pay, H Erdem, et al.
Clinical and Experimental Rheumatology
|
November 14, 2007
Dendritic cell subsets and type I interferon system in Behçet's disease: does functional abnormality in plasmacytoid dendritic cells contribute to Th1 polarization?
S Pay, I Simsek, H Erdem, et al.
Clinical and Experimental Rheumatology
|
November 14, 2007
Synovial lymphoid neogenetic factors in Behçet's synovitis: do they play a role in self-limiting and subacute course of arthritis?
S Pay, U Musabak, I Simsek, et al.
Endoscopy
|
May 1, 1999
Hemosuccus pancreaticus treated by transvascular selective arterial embolization
H Akpinar, O Dicle, E Ellidokuz, et al.
Clinical and Experimental Rheumatology
|
November 14, 2007
Serum MMP-2 and MMP-9 in patients with Behçet's disease: do their higher levels correlate to vasculo-Behçet's disease associated with aneurysm formation?
S Pay, T Abbasov, H Erdem, et al.
Clinical and Experimental Rheumatology
|
October 3, 2009
IFNAR1 and IFNAR2 polymorphisms in patients with Behçet's disease
S Pay, U Musabak, V Cobankara, et al.
Clinical and Experimental Rheumatology
|
October 3, 2009
IL-18 promoter polymorphisms confer susceptibility to Behçet's disease, particularly to the mucocutaneous form, in a Turkish population
F Keskin, S Pay, U Musabak, et al.
Pancreas
|
October 9, 2001
Inhibition of inducible nitric oxide synthase reduces bacterial translocation in a rat model of acute pancreatitis
I Simsek, M R Mas, M Yasar, et al.
Osteoarthritis and Cartilage
|
February 15, 2021
A Phase 2b randomized trial of lorecivivint, a novel intra-articular CLK2/DYRK1A inhibitor and Wnt pathway modulator for knee osteoarthritis
Y Yazici, T E McAlindon, A Gibofsky, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 31) with videos related to
Sort By:
Page
of 4
Clinical and Experimental Rheumatology
|
October 3, 2009
Pronounced interferon-alpha production from plasmacytoid dendritic cells in patients with Behçet's disease following CpG D ODN stimulation
S Pay, A Pekel, I Simsek, et al.
Rheumatology International
|
October 6, 2005
Serum interleukin-18 levels in patients with Behçet's disease. Is its expression associated with disease activity or clinical presentations?
U Musabak, S Pay, H Erdem, et al.
Clinical and Experimental Rheumatology
|
November 14, 2007
Dendritic cell subsets and type I interferon system in Behçet's disease: does functional abnormality in plasmacytoid dendritic cells contribute to Th1 polarization?
S Pay, I Simsek, H Erdem, et al.
Clinical and Experimental Rheumatology
|
November 14, 2007
Synovial lymphoid neogenetic factors in Behçet's synovitis: do they play a role in self-limiting and subacute course of arthritis?
S Pay, U Musabak, I Simsek, et al.
Endoscopy
|
May 1, 1999
Hemosuccus pancreaticus treated by transvascular selective arterial embolization
H Akpinar, O Dicle, E Ellidokuz, et al.
Clinical and Experimental Rheumatology
|
November 14, 2007
Serum MMP-2 and MMP-9 in patients with Behçet's disease: do their higher levels correlate to vasculo-Behçet's disease associated with aneurysm formation?
S Pay, T Abbasov, H Erdem, et al.
Clinical and Experimental Rheumatology
|
October 3, 2009
IFNAR1 and IFNAR2 polymorphisms in patients with Behçet's disease
S Pay, U Musabak, V Cobankara, et al.
Clinical and Experimental Rheumatology
|
October 3, 2009
IL-18 promoter polymorphisms confer susceptibility to Behçet's disease, particularly to the mucocutaneous form, in a Turkish population
F Keskin, S Pay, U Musabak, et al.
Pancreas
|
October 9, 2001
Inhibition of inducible nitric oxide synthase reduces bacterial translocation in a rat model of acute pancreatitis
I Simsek, M R Mas, M Yasar, et al.
Osteoarthritis and Cartilage
|
February 15, 2021
A Phase 2b randomized trial of lorecivivint, a novel intra-articular CLK2/DYRK1A inhibitor and Wnt pathway modulator for knee osteoarthritis
Y Yazici, T E McAlindon, A Gibofsky, et al.
Page
of 4